Earlier today Florida Governor Ron DeSantis responded to the Biden administration's political effort to stop Floridians from receiving COVID-19 treatment.
Late yesterday evening, without notice, the Biden FDA blocked monoclonal antibody treatments by revoking the emergency use authorization for the therapeutic.
Today thousands of Floridians wake up to hear they are no longer eligible for treatment.
FLORIDA - Governor Ron DeSantis is demanding the Biden Administration reverse its sudden and reckless decision to revoke emergency use authorization for Regeneron and Eli Lilly monoclonal antibody treatments.
This abrupt and unilateral action by the Biden Administration will prevent access to lifesaving treatments for Floridians and Americans.
"Rather than giving Americans the option for various COVID treatments, the FDA and the Biden Administration issued their royal decree, taking away the very thing that is proven to reduce hospitalizations and save lives," said Lieutenant Governor Jeanette Nuñez.
"Monoclonal antibody treatments like Regeneron have had a positive impact for thousands of Floridians. For the CDC and FDA, which have been consistently inconsistent throughout the entire pandemic, to restrict treatment does nothing but put individuals at risk."
It's becoming increasingly difficult to discern fact from fiction, and unfortunately the media has a strong bias. They spin stories to make conservatives look bad and will go to great lengths to avoid reporting on the good that comes from conservative policies. There are a few shining lights in the media landscape-brave conservative outlets that report the truth and offer a different perspective. We must support conservative outlets like this one and ensure that our voices are heard.
Elections have consequences, so it is important that voters who want to save our democracy, should v
Tuesday, January 25, 2022
Florida Governor Ron DeSantis Responds to Biden Administration Effort to Block COVID Treatments and Kill Floridians
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment